{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:49:33Z","timestamp":1777906173436,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s10815-022-02477-1","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T06:14:26Z","timestamp":1648534466000},"page":"1169-1176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of letrozole on follicular fluid steroids concentrations in cancer patients undergoing oocyte cryopreservation"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2995-2112","authenticated-orcid":false,"given":"Chiara","family":"Dallagiovanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Reschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Polledri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Pinna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Ciaffaglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Cuce\u2019","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgardo","family":"Somigliana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Fustinoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,29]]},"reference":[{"issue":"1","key":"2477_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3322\/caac.21203","volume":"64","author":"C DeSantis","year":"2014","unstructured":"DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64(1):52\u201362.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2477_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3322\/caac.21235","volume":"64","author":"CE DeSantis","year":"2014","unstructured":"DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252\u201371.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2477_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10549-016-3989-3","volume":"160","author":"EK Hartman","year":"2016","unstructured":"Hartman EK, Eslick GD. The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis. Breast Cancer Res Treat. 2016;160(2):347\u201360.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"2477_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.breast.2014.05.024","volume":"23","author":"N Tomasi-Cont","year":"2014","unstructured":"Tomasi-Cont N, Lambertini M, Hulsbosch S, Peccatori AF, Amant F. Strategies for fertility preservation in young early breast cancer patients. Breast. 2014;23(5):503\u201310.","journal-title":"Breast"},{"issue":"9869","key":"2477_CR5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","volume":"381","author":"C Davies","year":"2013","unstructured":"Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor positive breast cancer: ATLAS, a randomised trial. Lancet. 2013;381(9869):805\u201316.","journal-title":"Lancet"},{"issue":"10","key":"2477_CR6","doi-asserted-by":"publisher","first-page":"djv202","DOI":"10.1093\/jnci\/djv202","volume":"107","author":"NC Llarena","year":"2015","unstructured":"Llarena NC, Estevez SL, Tucker SL, Jeruss JS. Impact of Fertility Concerns on Tamoxifen Initiation and Persistence. J Natl Cancer Inst. 2015;107(10):djv202.","journal-title":"J Natl Cancer Inst."},{"issue":"3","key":"2477_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.6004\/jnccn.2016.0038","volume":"14","author":"AG Waks","year":"2016","unstructured":"Waks AG, Partridge AH. Fertility preservation in patients with breast Cancer: necessity, methods, and safety. J Natl Compr Cancer Netw. 2016;14(3):355\u201363.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"9950","key":"2477_CR8","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S0140-6736(14)60834-5","volume":"384","author":"M De Vos","year":"2014","unstructured":"De Vos M, Smitz J, Woodruff TK. Fertility preservation in women with cancer. Lancet. 2014;384(9950):1302\u201310.","journal-title":"Lancet"},{"issue":"19","key":"2477_CR9","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","volume":"23","author":"K Oktay","year":"2005","unstructured":"Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23(19):4347\u201353.","journal-title":"J Clin Oncol"},{"issue":"10","key":"2477_CR10","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1210\/jc.2006-0962","volume":"91","author":"K Oktay","year":"2006","unstructured":"Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab. 2006;91(10):3885\u201390.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2477_CR11","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/0960-0760(90)90460-3","volume":"37","author":"AS Bhatnagar","year":"1990","unstructured":"Bhatnagar AS, Hausler A, Schieweck K, Lang M, Bowman R. Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor. J Steroid Biochem Mol Biol. 1990;37(6):1021\u20137.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"2477_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2165\/00003495-199958020-00003","volume":"58","author":"VC Njar","year":"1999","unstructured":"Njar VC, Brodie AM. Comprehensive pharmacology and clinical efficacy of aromatase inhibitors. Drugs. 1999;58(2):233\u201355.","journal-title":"Drugs"},{"issue":"10","key":"2477_CR13","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1080\/09513590.2016.1177013","volume":"32","author":"N Pereira","year":"2016","unstructured":"Pereira N, Hancock K, Cordeiro CN, Lekovich JP, Schattman GL, Rosenwaks Z. Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytesdagger. Gynecol Endocrinol. 2016;32(10):823\u20136.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2477_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12958-017-0288-8","volume":"15","author":"J Haas","year":"2017","unstructured":"Haas J, Bassil R, Meriano J, Samara N, Barzilay E, Gonen N, et al. Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome? Reprod Biol Endocrinol. 2017;15(1):70.","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"2477_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10549-020-06031-4","volume":"186","author":"MB Moravek","year":"2021","unstructured":"Moravek MB, Confino R, Lawson AK, Smith KN, Kazer RR, Klock SC, Gradishar WJ, Jeruss JS, Pavone ME. Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation. Breast Cancer Res Treat. 2021;186(2):429\u201337. https:\/\/doi.org\/10.1007\/s10549-020-06031-4.","journal-title":"Breast Cancer Res Treat"},{"key":"2477_CR16","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/aogs.13146","volume":"96","author":"V Sarais","year":"2017","unstructured":"Sarais V, Paffoni A, Pagliardini L, Filippi F, Martinelli F, Mangili G, et al. Long-acting recombinant follicle-stimulating hormone in random-start ovarian stimulation protocols for fertility preservation in women with cancer. Acta Obstet Gynecol Scand. 2017;96:949\u201353.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"2477_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/jcm10010119","volume":"10","author":"G Grassi","year":"2020","unstructured":"Grassi G, Polledri E, Fustinoni S, Chiodini I, Ceriotti F, D\u2019Agostino S, Filippi F, Somigliana E, Mantovani G, Arosio M, Morelli V. Hyperandrogenism by Liquid Chromatography Tandem Mass Spectrometry in PCOS: Focus on Testosterone and Androstenedione. J Clin Med. 2020;10(1):119.","journal-title":"J Clin Med"},{"issue":"2","key":"2477_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/humupd\/dmz046","volume":"26","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang C, Shu J, Guo J, Chang HM, Leung PCK, Sheng JZ, Huang H. Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis. Hum Reprod Update. 2020;26(2):247\u201363.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"2477_CR19","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/humrep\/deaa029","volume":"35","author":"A Marklund","year":"2020","unstructured":"Marklund A, Eloranta S, Wikander I, Kitlinski ML, Lood M, Nedstrand E, Thurin-Kjellberg A, Zhang P, Bergh J, Rodriguez-Wallberg KA. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study. Hum Reprod. 2020;35(4):929\u201338. https:\/\/doi.org\/10.1093\/humrep\/deaa029.","journal-title":"Hum Reprod"},{"issue":"1","key":"2477_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12958-019-0483-x","volume":"17","author":"X Yang","year":"2019","unstructured":"Yang X, Lin G, Lu G, Gong F. Letrozole supplementation during controlled ovarian stimulation in expected high responders: a pilot randomized controlled study. Reprod Biol Endocrinol. 2019;17(1):43.","journal-title":"Reprod Biol Endocrinol"},{"issue":"22","key":"2477_CR21","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1200\/JCO.2014.59.3723","volume":"33","author":"K Oktay","year":"2015","unstructured":"Oktay K, Turan V, Bedoschi G, Pacheco FS, Moy F. Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer. J Clin Oncol. 2015;33(22):2424\u20139. https:\/\/doi.org\/10.1200\/JCO.2014.59.3723.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2477_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.fertnstert.2012.09.028","volume":"99","author":"Practice Committees of American Society for Reproductive M, Society for Assisted Reproductive T","year":"2013","unstructured":"Practice Committees of American Society for Reproductive M, Society for Assisted Reproductive T. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99(1):37\u201343.","journal-title":"Fertil Steril."},{"issue":"1","key":"2477_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.fertnstert.2005.01.117","volume":"84","author":"JA Garcia-Velasco","year":"2005","unstructured":"Garcia-Velasco JA, Moreno L, Pacheco A, Guill\u00e9n A, Duque L, Requena A, Pellicer A. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril. 2005;84(1):82\u20137. https:\/\/doi.org\/10.1016\/j.fertnstert.2005.01.117.","journal-title":"Fertil Steril"},{"issue":"6","key":"2477_CR24","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.fertnstert.2007.05.003","volume":"89","author":"CY Andersen","year":"2008","unstructured":"Andersen CY, Lossl K. Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-M\u00fcllerian hormone and inhibin-B. Fertil Steril. 2008;89(6):1760\u20135. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.05.003.","journal-title":"Fertil Steril"},{"issue":"1","key":"2477_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12958-018-0443-x","volume":"17","author":"O Goldrat","year":"2019","unstructured":"Goldrat O, Van Den Steen G, Gonzalez-Merino E, Dech\u00e8ne J, Gervy C, Delbaere A, Devreker F, De Maertelaer V, Demeestere I. Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers. Reprod Biol Endocrinol. 2019;17(1):3. https:\/\/doi.org\/10.1186\/s12958-018-0443-x.","journal-title":"Reprod Biol Endocrinol"},{"issue":"8","key":"2477_CR26","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1093\/humrep\/den131","volume":"23","author":"K Lossl","year":"2008","unstructured":"Lossl K, Andersen CY, Loft A, Freiesleben NL, Bangsb\u00f8ll S, Andersen AN. Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial Hum Reprod. 2008;23(8):1820\u20139. https:\/\/doi.org\/10.1093\/humrep\/den131.","journal-title":"A randomized controlled trial Hum Reprod"},{"issue":"10","key":"2477_CR27","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1093\/humrep\/del221","volume":"21","author":"K Lossl","year":"2006","unstructured":"Lossl K, Andersen AN, Loft A, Freiesleben NL, Bangsb\u00f8ll S, Andersen CY. Androgen priming using aromatase inhibitor and hCG during early-follicular-phase GnRH antagonist down-regulation in modified antagonist protocols. Hum Reprod. 2006;21(10):2593\u2013600. https:\/\/doi.org\/10.1093\/humrep\/del221.","journal-title":"Hum Reprod"},{"issue":"1","key":"2477_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4103\/0974-1208.153125","volume":"8","author":"NL Carpintero","year":"2015","unstructured":"Carpintero NL, Su\u00e1rez OA, Varea CG, Rioja RG, Mangas CC. Variability between the follicular steroid hormone levels in different follicles of the same patient and between patients. J Hum Reprod Sci. 2015;8(1):37\u201342. https:\/\/doi.org\/10.4103\/0974-1208.153125.","journal-title":"J Hum Reprod Sci"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-022-02477-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-022-02477-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-022-02477-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T07:28:10Z","timestamp":1652513290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-022-02477-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,29]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["2477"],"URL":"https:\/\/doi.org\/10.1007\/s10815-022-02477-1","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,29]]},"assertion":[{"value":"21 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Edgardo SOMIGLIANA received during the last three years grants of research from Ferring and Merck-Serono. He also received honoraria from Theramex, Gedeon-Richter and Merck-Serono. All the other authors do not have any financial disclosure to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosure statement"}}]}}